微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -0.4% | 97.65% | 98.23% | 36/56 | -5.91% | 荣昌生物 | 84.13% | 行业排名> |
| 2026-06-30 | -22.62% | -41.29% | -128.72% | 48/56 | -10.1% | 荣昌生物 | 72.94% | 行业排名> |
| 2026-03-31 | -9.89% | -69.06% | 68.32% | 48/56 | -11.99% | 荣昌生物 | 8.68% | 行业排名> |
| 2025-12-31 | -31.22% | 5.19% | -83.54% | 48/56 | -3.42% | 信诺维 | 42.93% | 行业排名> |
| 2025-09-30 | -17.01% | 20.63% | -6.25% | 46/56 | 1.66% | 特宝生物 | 23.82% | 行业排名> |
| 2025-06-30 | -16.01% | -17.98% | -173.68% | 46/56 | -0.29% | 特宝生物 | 15.74% | 行业排名> |
| 2025-03-31 | -5.85% | 3.15% | 82.24% | 46/56 | -0.09% | 神州细胞 | 36.86% | 行业排名> |
| 2024-12-31 | -32.93% | 43.91% | -53.66% | 47/56 | -1.97% | 特宝生物 | 37.66% | 行业排名> |
| 2024-09-30 | -21.43% | 61.95% | -57.92% | 46/56 | 2.32% | 特宝生物 | 26.65% | 行业排名> |
| 2024-06-30 | -13.57% | -100.61% | -124.67% | 47/56 | 0.76% | 特宝生物 | 16.5% | 行业排名> |
| 2024-03-31 | -6.04% | 2% | 89.71% | 46/56 | 0.71% | 西藏药业 | 8.94% | 行业排名> |
| 2023-12-31 | -58.71% | 84.49% | -4.24% | 49/56 | 1.58% | 特宝生物 | 35.44% | 行业排名> |
| 2023-09-30 | -56.32% | 2% | -102.54% | 48/56 | 3.57% | 西藏药业 | 25.92% | 行业排名> |
| 2023-06-30 | 2214.89% | 2072.82% | 685.25% | 1/56 | 48.41% | 智翔金泰 | 2214.89% | 行业排名> |
| 2022-12-31 | -378.45% | -310.98% | -237.09% | 51/56 | -6.01% | 西藏药业 | 9.54% | 行业排名> |
| 2022-06-30 | -112.27% | 2% | -162.59% | 49/56 | 1.15% | 智飞生物 | 35.99% | 行业排名> |
| 2021-12-31 | 179.38% | 2% | 2% | 1/56 | 15.48% | 智飞生物 | 27.99% | 行业排名> |